TMEM16A ameliorates vascular remodeling by suppressing autophagy via inhibiting Bcl-2-p62 complex formation

Xiao-Fei Lv1, Ya-Juan Zhang1, Xiu Liu1

  • 1Department of Pharmacology and Cardiac & Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.

Theranostics
|April 1, 2020
PubMed

Insights

Transmembrane member 16A (TMEM16A) prevents vascular autophagy and remodeling by regulating interactions between p62, Bcl-2, Beclin-1, and VPS34. TMEM16A overexpression inhibits autophagy, while its downregulation promotes it, impacting vascular smooth muscle cell proliferation.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Transmembrane member 16A (TMEM16A) is implicated in vascular smooth muscle cell (SMC) proliferation and remodeling.
  • Autophagy plays crucial roles in vascular SMC physiology.
  • The interplay between TMEM16A and autophagy in vascular remodeling requires elucidation.

Purpose of the Study:

  • To investigate the relationship between TMEM16A and autophagy in the context of vascular remodeling.
  • To determine the molecular mechanisms by which TMEM16A influences autophagy and SMC behavior.

Main Methods:

  • Generation of a TMEM16A-overexpressing transgenic mouse model specifically in vascular SMCs.
  • Utilized immunofluorescence, electron microscopy, co-immunoprecipitation, and Western blotting.
  • Assessed autophagy markers (LC3B), autophagic flux, and protein-protein interactions in response to angiotensin II (AngII) stimulation.

Main Results:

  • Hypertension-induced aortic remodeling correlated with decreased TMEM16A expression and activated autophagy.
  • TMEM16A overexpression inhibited AngII-induced autophagy and SMC proliferation in mouse aortas and isolated SMCs.
  • TMEM16A regulated autophagy independently of mTOR but via modulation of vacuolar protein sorting 34 (VPS34) kinase activity and interaction with p62, Bcl-2, and Beclin-1.

Conclusions:

  • TMEM16A acts as a critical regulator of vascular autophagy and remodeling.
  • TMEM16A controls a molecular complex involving p62, Bcl-2, Beclin-1, and VPS34.
  • Modulating TMEM16A activity offers a potential therapeutic strategy for vascular remodeling-related diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K